Skip to main content

Table 1 Clinical differences between cirrhotic and non-cirrhotic patients with HCC

From: Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis

Clinical parameters

Non-cirrhosis (n = 328, %)

Cirrhosis (n = 675, %)

P-value

Clinical parameters

Non-cirrhosis (n = 328, %)

Cirrhosis (n = 675, %)

P-value

Gender

0.778

ALT (IU/L)

0.659

Male

275 (83.8)

570 (84.5)

 

≥ 50

112 (34.1)

240 (35.5)

 

Female

53 (16.2)

105 (15.5)

 

< 50

216 (65.9)

435 (64.5)

 

Age (years)

0.014

AST (IU/L)

0.385

≥ 60

101 (30.9)

152 (22.5)

 

≥ 40

153 (46.6)

334 (49.5)

 

< 60

227 (69.1)

523 (77.5)

 

< 40

175 (53.4)

341 (50.5)

 

HBV-DNA (copies/mL)

0.002

ALB (g/L)

0.054

≥ 103

169 (51.4)

397 (58.8)

 

≥ 40

224 (68.2)

419 (62.1)

 

< 103

159 (48.6)

278 (41.2)

 

< 40

104 (31.8)

256 (37.9)

 

HBeAg

0.002

GGT (IU/L)

0.363

Positive

43 (13.1)

149 (22.1)

 

≥ 60

170 (51.7)

329 (48.7)

 

Negative

285 (86.9)

526 (77.9)

 

< 60

158 (48.3)

346 (51.3)

 

AFP (ng/mL)

0.032

Child–pugh

0.961

≤ 20

116 (35.3)

227 (33.6)

 

A

323 (98.6)

666 (98.6)

 

20–400

65 (19.7)

182 (27.0)

 

B

5 (1.4)

9 (1.4)

 

≥ 400

147 (45.0)

266 (39.4)

 

Tumor diameter, mean (SD), cm

7.44 (3.91)

5.53 (3.25)

< 0.001

WBC (× 109/L)

< 0.001

Tumor number

0.015

≥ 4

297 (90.6)

502 (74.3)

 

Multi

36 (11.1)

113 (16.8)

 

< 4

31 (9.4)

173 (25.7)

 

Single

292 (88.9)

562 (83.2)

 

NEU (× 109/L)

< 0.001

Differentiation

0.628

≥ 3.56

184 (56.0)

239 (35.4)

 

I + II

193 (58.8)

383 (56.8)

 

< 3.56

144 (44.0)

436 (64.6)

 

III + IV

135 (41.2)

292 (43.2)

 

LYM (× 109/L)

0.089

MVI

0.24

≥ 1.1

261 (79.5)

505 (74.8)

 

Present

128 (38.9)

238 (35.2)

 

< 1.1

67 (20.5)

238 (35.2)

 

Absent

200 (61.1)

437 (64.8)

 

PLT (× 109/L)

< 0.001

Satellite lesion

0.328

≥ 100

275 (83.8)

409 (60.6)

 

Present

48 (14.5)

83 (12.3)

 

< 100

53 (16.2)

266 (39.4)

 

Absent

280 (85.5)

592 (87.7)

 

PT (s)

< 0.001

Resection

< 0.001

≥ 12.8

48 (14.5)

186 (27.5)

 

Anatomic

187 (56.9)

287 (42.5)

 

< 12.8

280 (85.5)

489 (72.5)

 

Non-anatomic

141 (43.1)

388 (57.5)

 

INR

< 0.001

Blood loss (mL)

0.872

≥ 1.15

47 (14.2)

172 (25.5)

 

≥ 400

272 (82.9)

567 (84.0)

 

< 1.15

281 (85.8)

503 (74.5)

 

< 400

56 (17.1)

108 (16.0)

 

Fib (g/L)

< 0.001

Transfusion

0.734

≥ 2

297 (90.6)

538 (79.7)

 

Yes

51 (15.6)

109 (16.1)

 

< 2

31 (9.4)

137 (20.3)

 

No

277 (84.4)

566 (83.9)

 

TBIL (μmol/L)

0.02

    

≥ 28

8 (2.3)

36 (5.4)

     

< 28

320 (97.7)

639 (94.6)

     
  1. Bold numbers indicate statistical significance
  2. HBV-DNA, hepatitis B virus deoxyribonucleic acid; HBeAg, hepatitis B e antigen; AFP, alpha-fetoprotein; WBC, white blood cell; NEU, neutrophil; LYM, lymphocyte; PLT, platelet; PT, prothrombin time; s, second; INR, international normalized ratio; Fib, fibrinogen; TBIL, total bilirubin; ALT, alanine transaminase; AST, aspartate aminotransferase; ALB, albumin; GGT, gamma-glutamyl transpeptidase; SD, standard deviation; MVI, microvascular invasion